2023-03-09 09:04:51 ET
- Hikma Pharmaceuticals ( OTCPK:HKMPY ) ( OTCPK:HKMPF ) said it launched four new sterile injectable drugs in Canada.
- The company added that all of the drugs, which will be launched soon, represent the first or second generic versions of their molecules on the Canadian market.
- The products are: Dantrolene Sodium Injection, USP, 20 mg Vial; Micafungin Sodium Injection, 50 mg and 100 mg Vials; Mitomycin Injection, USP, 20 mg Vial; and Progesterone Injection, USP, 50 mg/mL, 10 mL Vial.
- With the launch, Hikma now markets ~30 different sterile injectable drugs in Canada, and plans to launch up to 13 more in 2023.
For further details see:
Hikma launches 4 sterile injectable drugs in Canada